Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: a challenge for the generalist.

G Catalina1, V Navarro

  • 1Connecticut Emerging Infections Program, Yale University, New Haven, USA.

Hospital Practice (1995)
|January 26, 2000
PubMed
Summary

Most hepatitis C infections become chronic, potentially leading to severe liver disease like cirrhosis. New treatment options, including adding ribavirin to interferon therapy, offer improved management for the growing number of patients with progressive hepatitis C.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Effectiveness of a nutrition education programme for individuals with celiac disease and their supporters through social media (GLUTLEARN project)' Comput. Biol. Med. 184 (2025) 109505.

Computers in biology and medicine·2026
Same author

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

ESMO open·2026
Same author

Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

ESMO gastrointestinal oncology·2026
Same author

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

ESMO open·2025
Same author

Discriminating factors in access to video-EEG for epilepsy surgery in a French tertiary epilepsy center.

Revue neurologique·2024
Same author

Novel trial designs for patients with gastrointestinal stromal tumor.

ESMO open·2024

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Hepatitis C virus (HCV) infection frequently leads to chronic liver disease.
  • A significant portion of the U.S. population (nearly 2%) is infected with HCV.
  • Chronic hepatitis C can remain asymptomatic for extended periods before progressing to serious complications such as cirrhosis.

Purpose of the Study:

  • To highlight the increasing clinical relevance of managing chronic hepatitis C.
  • To inform healthcare providers about the evolving treatment landscape for hepatitis C.
  • To underscore the potential for disease progression in a large patient cohort.

Main Methods:

  • Review of current epidemiological data on hepatitis C prevalence in the U.S.
  • Analysis of the natural history and progression of untreated chronic hepatitis C.
  • Summary of recent modifications in hepatitis C therapeutic regimens.

Main Results:

  • The high prevalence of hepatitis C necessitates increased clinical attention.
  • Chronic hepatitis C poses a long-term risk for liver cirrhosis and other severe outcomes.
  • Combination therapy with interferon and ribavirin represents an updated treatment approach.

Conclusions:

  • Clinicians must anticipate a rising incidence of advanced hepatitis C cases.
  • Early detection and management are crucial for mitigating complications.
  • Updated treatment protocols, including interferon and ribavirin, offer new therapeutic avenues.

Related Experiment Videos